Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 38 results.
User Information
Export Records
  1. 1.   Urinary estrogen metabolites and gastric cancer risk among postmenopausal women
  2. Camargo, M. Constanza; Song, Minkyo; Xu,Xia; Zhao, Isaac; Sampson, Joshua N.; Etemadi, Arash; Brenner, Hermann; Lee, Hwi-Won; Trabert, Britton; Holleczek, Bernd; Schoettker, Ben; Spaid, Kathleen; Dawsey, Sanford M.; Lee, Sangjun; Shimura, Takaya; Park, Sue K.; Malekzadeh, Reza; Kang, Daehee; Rabkin, Charles S.
  3. CANCER REPORTS. 2021, Nov 11;
  1. 2.   Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome
  2. Henríquez, Soledad; Kohen, Paulina; Xu,Xia; Villarroel, Claudio; Muñoz, Alex; Godoy, Ana; Strauss, Jerome F; Devoto, Luigi
  3. Human reproduction (Oxford, England). 2020, JUL; 35(7): 1655-1665.
  1. 3.   Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease
  2. Eldridge, Ronald C.; Wentzensen, Nicolas; Pfeiffer, Ruth M.; Brinton, Louise A.; Hartge, Patricia; Guillemette, Chantal; Kemp, Troy J.; Pinto, Ligia A.; Trabert, Britton
  3. Cancer causes & control : CCC. 2020, Apr; 31(4): 309-320.
  1. 4.   Do metabolites account for higher serum steroid hormone levels measured by RIA compared to mass spectrometry?
  2. Stanczyk, Frank Z; Xu, Xia; Sluss, Patrick M; Brinton, Louise A; McGlynn, Katherine A
  3. Clinica chimica acta; international journal of clinical chemistry. 2018, Sep; 484: 223-225.
  1. 5.   Utility of F-18-fluoroestradiol (F-18-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy
  2. Lin, F. I.; Gonzalez, E. M.; Kummar, S.; Do, K.; Shih, J.; Adler, Stephen; Kurdziel, K. A.; Ton, A.; Turkbey, B.; Jacobs, P. M.; Bhattacharyya, S.; Chen, A. P.; Collins, J. M.; Doroshow, J. H.; Choyke, P. L.; Lindenberg, M. L.
  3. European Journal of Nuclear Medicine and Molecular Imaging. 2017, Mar; 44(3): 500-508.
  1. 6.   Comparison of estrone and 17 beta-estradiol levels in commercial goat and cow milk
  2. Farlow, D. W.; Xu, X.; Veenstra, T. D.
  3. Journal of Dairy Science. 2012, Apr; 95(4): 1699-1708.
  1. 7.   Urinary Estrogens and Estrogen Metabolites and Subsequent Risk of Breast Cancer among Premenopausal Women
  2. Eliassen, A. H.; Spiegelman, D.; Xu, X.; Keefer, L. K.; Veenstra, T. D.; Barbieri, R. L.; Willett, W. C.; Hankinson, S. E.; Ziegler, R. G.
  3. Cancer Research. 2012, Feb; 72(3): 696-706.
  1. 8.   Urinary Estrogen Metabolites and Prostate Cancer Risk: A Pilot Study
  2. Kosti, O.; Xu, X.; Veenstra, T. D.; Hsing, A. W.; Chu, L. W.; Goldman, L.; Bebu, I.; Collins, S.; Dritschilo, A.; Lynch, J. H.; Goldman, R.
  3. Prostate. 2011, Apr; 71(5): 507-516.
  1. 9.   A new approach to measuring estrogen exposure and metabolism in epidemiologic studies
  2. Ziegler, R. G.; Faupel-Badger, J. M.; Sue, L. Y.; Fuhrman, B. J.; Falk, R. T.; Boyd-Morin, J.; Henderson, M. K.; Hoover, R. N.; Veenstra, T. D.; Keefer, L. K.; Xu, X.
  3. Journal of Steroid Biochemistry and Molecular Biology. 2010, Aug; 121(3-5): 538-545.
  1. 10.   Comparison of estrogens and estrogen metabolites in human breast tissue and urine
  2. Taioli, E.; Im, A.; Xu, X.; Veenstra, T. D.; Ahrendt, G.; Garte, S.
  3. Reproductive Biology and Endocrinology. 2010, Aug; 8: 7.
  1. 11.   Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies
  2. Fuhrman, B. J.; Xu, X.; Falk, R. T.; Hankinson, S. E.; Veenstra, T. D.; Keefer, L. K.; Ziegler, R. G.
  3. International Journal of Biological Markers. 2010, Oct-Dec; 25(4): 185-194.
  1. 12.   The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer
  2. Diaz, R.; Nguewa, P. A.; Diaz-Gonzalez, J. A.; Hamel, E.; Gonzalez-Moreno, O.; Catena, R.; Serrano, D.; Redrado, M.; Sherris, D.; Calvo, A.
  3. British Journal of Cancer. 2009 100(6): 932-940.
  1. 13.   Reproducibility of Fifteen Urinary Estrogens and Estrogen Metabolites over a 2-to 3-Year Period in Premenopausal Women
  2. Eliassen, A. H.; Ziegler, R. G.; Rosner, B.; Veenstra, T. D.; Roman, J. M.; Xu, X.; Hankinson, S. E.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(11): 2860-2868.
  1. 14.   Quantitative measurement of endogenous estrogen metabolites, risk-factors for development of breast cancer, in commercial milk products by LC-MS/MS
  2. Farlow, D. W.; Xu, X.; Veenstra, T. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2009 877(13): 1327-1334.
  1. 15.   Serum Estrogen Metabolites and Systolic Blood Pressure Among Middle-Aged and Older Women and Men
  2. Masi, C. M.; Hawkley, L. C.; Xu, X.; Veenstra, T. D.; Cacioppo, J. T.
  3. American Journal of Hypertension. 2009 22(11): 1148-1153.
  1. 16.   Relaxing Effects of Phytoestrogen alpha-Zearalanol on Rat Thoracic Aorta Rings in Vitro
  2. Wang, W.; Jiang, D. Q.; Zhu, Y. F.; Liu, W.; Duan, J. H.; Dai, S. L.
  3. Chinese Journal of Physiology. 2009 52(2): 99-105.
  1. 17.   A Liquid Chromatography-Mass Spectrometry Method for the Simultaneous Measurement of 15 Urinary Estrogens and Estrogen Metabolites: Assay Reproducibility and Interindividual Variability
  2. Falk, R. T.; Xu, X.; Keefer, L.; Veenstra, T. D.; Ziegler, R. G.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(12): 3411-3418.
  1. 18.   Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198
  2. LaVallee, T. M.; Burke, P. A.; Swartz, G. M.; Hamel, E.; Agoston, G. E.; Shah, J.; Suwandi, L.; Hanson, A. D.; Fogler, W. E.; Sidor, C. F.; Treston, A. M.
  3. Molecular Cancer Therapeutics. 2008 7(6): 1472-1482.
  1. 19.   Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicularis)
  2. Scott, L. M.; Xu, X.; Veenstra, T. D.; Tooze, J. A.; Wood, C. E.; Register, T. C.; Kock, N. D.; Cline, J. M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(10): 2594-2602.
  1. 20.   Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry
  2. Xu, X.; Roman, J. M.; Issaq, H. J.; Keefer, L. K.; Veenstra, T. D.; Zieger, R. G.
  3. Analytical Chemistry. 2007, Oct; 79(20): 7813-7821.
  1. 21.   Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines
  2. Hurt, E. M.; Thomas, S. B.; Peng, B.; Farrar, W. L.
  3. British Journal of Cancer. 2007, Oct; 97(8): 1116-1123.
  1. 22.   Lower levels of urinary 2-hydroxyestrogens in polycystic ovary syndrome
  2. Salih, S.; Xu, X.; Veenstra, T. D.; Duleba, A. J.; Fouad, H.; Nagamani, M.; Al-Hendy, A.
  3. Journal of Clinical Endocrinology & Metabolism. 2007, Aug; 92(8): 3285-3291.
  1. 23.   Pharmacokinetics, pharmacodynamics and drug metabolism - Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol
  2. Lakhani, N. J.; Sparreboom, A.; Xu, X.; Veenstra, T. D.; Venitz, J.; Dahut, W. L.; Figg, W. D.
  3. Journal of Pharmaceutical Sciences. 2007, Jul; 96(7): 1821-1831.
  1. 24.   Integrated molecular profiling of SOD2 expression in multiple myeloma
  2. Hurt, E. M.; Thomas, S. B.; Peng, B. J.; Farrar, W. L.
  3. Blood. 2007, May; 109(9): 3953-3962.
  1. 25.   Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry
  2. Xu, X.; Roman, J. M.; Veenstra, T. D.; Van Anda, J.; Ziegler, R. G.; Issaq, H. J.
  3. Analytical Chemistry. 2006, MAR 1; 78(5): 1553-1558.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel